Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Oct. 31, 2018
Oct. 31, 2017
Revenues $ 21,260 $ 26,876
Operating costs and expenses:    
Cost of Revenues 14,239 15,431
Research and development 728 747
Selling, general and administrative 10,970 10,905
Legal fee expense 1,301 431
Total operating costs and expenses 27,238 27,514
Operating loss (5,978) (638)
Other income (expense):    
Interest 274 157
Other 47 36
Foreign exchange loss (324) (195)
Loss before income taxes (5,981) (640)
Benefit for income taxes
Net loss $ (5,981) $ (640)
Net loss per common share:    
Basic and diluted (in Dollars per share) $ (0.13) $ (0.01)
Weighted average common shares outstanding:    
Basic and diluted (in Shares) 47,186 46,914